Background and aims: Familial hypercholesterolaemia (FH) is a known major cause of premature heart disease. However, the risks of atherosclerotic disease in other vascular regions are less known. We determined the risk of major cardiovascular disease (CVD) outcomes associated with clinical FH.
Methods: In a retrospective cohort study (1 January, 1999 to 22 July, 2016), we randomly-matched 14,097 UK subjects with clinical FH diagnoses or characteristics (Simon-Broome definite or Dutch Lipid Clinic Score >8) to 42,506 subjects without FH by age, sex, general practice. We excluded those with CVD at baseline. Incident rates for coronary heart disease (CHD), stroke or transient ischaemic attack (TIA) and peripheral vascular disease (PVD) were estimated. Cox proportional hazards regression, stratified on matched-pairs, determined adjusted hazards ratios (HR) for incident CVD.
Results: During follow-up (median 13.8 years), incidence rates (95% CI) of CVD (per 1000 person-years) were 25.6 (24.8-26.3) in FH and 2.9 (2.8-3.1) in non-FH subjects. The risk of CHD, stroke/TIA and PVD was higher in FH compared to non-FH subjects: CHD (HR 10.63, 95% CI 9.82-11.49), stroke/TIA (HR 6.74, 95% CI 5.84-7.77), PVD (HR 7.17, 95% CI 6.08-8.46). The risk of CVD was greater in those with FH characteristics (HR 13.52, 95% CI 12.48-14.65) than those with clinical diagnoses (HR 1.66, 95% CI 1.42-1.93).
Conclusions: In addition to the recognised increased risk of CHD, subjects with FH have greatly elevated risk of stroke/TIA and PVD. This emphasises need for early diagnosis and preventive interventions beyond CHD, to reduce CVD risk in these individuals.
Keywords: Cardiovascular disease; Coronary heart disease; Epidemiology; Familial hypercholesterolaemia; Peripheral vascular disease; Stroke.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.
Familial hypercholesterolaemia in patients with ischaemic stroke or transient ischaemic attack.Eur J Neurol. 2018 Feb;25(2):260-267. doi: 10.1111/ene.13485. Epub 2017 Dec 14. Eur J Neurol. 2018. PMID: 29053901 Clinical Trial.
High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.Circulation. 2019 Jun 4;139(23):2642-2653. doi: 10.1161/CIRCULATIONAHA.118.038772. Epub 2019 Apr 29. Circulation. 2019. PMID: 31030544 Clinical Trial.
Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.Circulation. 2016 Jul 5;134(1):9-19. doi: 10.1161/CIRCULATIONAHA.116.022335. Circulation. 2016. PMID: 27358432 Free PMC article.
Aspirin Use in Adults: Cancer, All-Cause Mortality, and Harms: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Sep. Report No.: 13-05193-EF-1. Agency for Healthcare Research and Quality (US). 2015. PMID: 26491756 Free Books & Documents. Review.
[Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening].Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 2:1-9. Turk Kardiyol Dern Ars. 2014. PMID: 25693358 Review. Turkish.
Cited by 2 articles
The development of a theory informed behaviour change intervention to improve adherence to dietary and physical activity treatment guidelines in individuals with familial hypercholesterolaemia (FH).BMC Health Serv Res. 2020 Jan 8;20(1):27. doi: 10.1186/s12913-019-4869-4. BMC Health Serv Res. 2020. PMID: 31914998 Free PMC article.
Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million Patients.J Clin Med. 2019 Jul 23;8(7):1080. doi: 10.3390/jcm8071080. J Clin Med. 2019. PMID: 31340450 Free PMC article.